Toronto Dominion Bank lifted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 39.1% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 20,180 shares of the technology company’s stock after buying an additional 5,673 shares during the period. Toronto Dominion Bank’s holdings in Veeva Systems were worth $4,235,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also modified their holdings of VEEV. Patriot Financial Group Insurance Agency LLC raised its stake in Veeva Systems by 0.7% during the third quarter. Patriot Financial Group Insurance Agency LLC now owns 6,924 shares of the technology company’s stock worth $1,453,000 after acquiring an additional 48 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. increased its position in Veeva Systems by 1.2% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,307 shares of the technology company’s stock worth $904,000 after purchasing an additional 50 shares in the last quarter. Clearbridge Investments LLC lifted its stake in Veeva Systems by 0.4% in the 2nd quarter. Clearbridge Investments LLC now owns 11,682 shares of the technology company’s stock valued at $2,138,000 after purchasing an additional 52 shares during the last quarter. Park Place Capital Corp boosted its position in Veeva Systems by 11.5% in the third quarter. Park Place Capital Corp now owns 574 shares of the technology company’s stock valued at $120,000 after buying an additional 59 shares in the last quarter. Finally, Quintet Private Bank Europe S.A. boosted its position in Veeva Systems by 13.4% in the third quarter. Quintet Private Bank Europe S.A. now owns 516 shares of the technology company’s stock valued at $108,000 after buying an additional 61 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors.
Veeva Systems Trading Down 1.6 %
NYSE VEEV opened at $228.78 on Friday. The company has a market cap of $37.14 billion, a P/E ratio of 56.49, a PEG ratio of 2.03 and a beta of 0.82. The company has a fifty day simple moving average of $221.36 and a 200 day simple moving average of $204.01. Veeva Systems Inc. has a 12-month low of $170.25 and a 12-month high of $258.93.
Insider Activity
Analysts Set New Price Targets
VEEV has been the topic of several recent research reports. Stifel Nicolaus raised their price objective on Veeva Systems from $240.00 to $272.00 and gave the company a “buy” rating in a report on Friday, December 6th. Wells Fargo & Company lifted their price target on Veeva Systems from $275.00 to $285.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Truist Financial reaffirmed a “hold” rating and issued a $261.00 price objective (up previously from $207.00) on shares of Veeva Systems in a research note on Friday, December 6th. Needham & Company LLC lifted their target price on shares of Veeva Systems from $260.00 to $270.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Finally, Mizuho began coverage on shares of Veeva Systems in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $275.00 price target for the company. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and eighteen have given a buy rating to the company. According to data from MarketBeat, Veeva Systems currently has an average rating of “Moderate Buy” and a consensus price target of $255.35.
Read Our Latest Stock Analysis on Veeva Systems
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Stories
- Five stocks we like better than Veeva Systems
- What Are the FAANG Stocks and Are They Good Investments?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are Growth Stocks and Investing in Them
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.